Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Glycemic Variability (GLAIVE)

NCT: NCT02812927 · COMPLETED

NCT IDNCT02812927
StatusCOMPLETED
Start Date2012-09
Completion2014-09

Brief Summary

This study compared two methods of insulin infusion by syringe pumps to assess the impact of medical devices on the glycaemic variability in patients under IIT in ICU. The main objective of the study was to show the superiority of the infusion system which permitted to dedicate a line for the insulin administration on the "standard" installation in terms of control of glycaemic variability.

Frequently Asked Questions

What is Evaluation of Glycemic Variability (GLAIVE)?

Evaluation of Glycemic Variability (GLAIVE) is a clinical trial registered under NCT02812927. Current status: COMPLETED.

What is the status of NCT02812927?

The current status of NCT02812927 (Evaluation of Glycemic Variability (GLAIVE)) is: COMPLETED.

When did Evaluation of Glycemic Variability (GLAIVE) start?

Evaluation of Glycemic Variability (GLAIVE) started on 2012-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑